86 related articles for article (PubMed ID: 21817853)
21. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
22. [Identification of the SjARG novel gene and study on its protective potential as a vaccine].
Li Z; Yu XB; Wu ZD; Hu XC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Apr; 24(2):86-91. PubMed ID: 16862902
[TBL] [Abstract][Full Text] [Related]
23. Protection with a recombinant Hc of Clostridium Botulinum neurotoxin serotype A from Escherichia coli as an effective subunit vaccine.
Yu YZ; Sun ZW; Li N; Wang S; Wang RL; Yu WY
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):261-6. PubMed ID: 18932057
[TBL] [Abstract][Full Text] [Related]
24. [Production and immunogenicity analysis of conformation-stable fragment-C mutant of tetanus toxin].
Yu R; Hou L; Liu S; Yu C; Zhang X; Liu Y; Chen W
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):226-32. PubMed ID: 21650047
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with recombinant Ascaris suum 24-kilodalton antigen induces a Th1/Th2-mixed type immune response and confers high levels of protection against challenged Ascaris suum lung-stage infection in BALB/c mice.
Islam MK; Miyoshi T; Tsuji N
Int J Parasitol; 2005 Aug; 35(9):1023-30. PubMed ID: 15998515
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
[TBL] [Abstract][Full Text] [Related]
27. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
[TBL] [Abstract][Full Text] [Related]
29. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
[TBL] [Abstract][Full Text] [Related]
30. Strong protection against ricin challenge induced by a novel modified ricin A-chain protein in mouse model.
Zhang T; Yang H; Kang L; Gao S; Xin W; Yao W; Zhuang X; Ji B; Wang J
Hum Vaccin Immunother; 2015; 11(7):1779-87. PubMed ID: 26038805
[TBL] [Abstract][Full Text] [Related]
31. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
32. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
[TBL] [Abstract][Full Text] [Related]
33. Immunization with recombinant beta-tubulin from Trypanosoma evansi induced protection against T. evansi, T. equiperdum and T. b. brucei infection in mice.
Li SQ; Fung MC; Reid SA; Inoue N; Lun ZR
Parasite Immunol; 2007 Apr; 29(4):191-9. PubMed ID: 17371456
[TBL] [Abstract][Full Text] [Related]
34. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
[TBL] [Abstract][Full Text] [Related]
35. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).
Wu JR; Shien JH; Shieh HK; Chen CF; Chang PC
Vaccine; 2007 May; 25(21):4140-8. PubMed ID: 17449151
[TBL] [Abstract][Full Text] [Related]
36. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
[TBL] [Abstract][Full Text] [Related]
37. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
38. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.
Alaeddine F; Keller N; Leepin A; Hemphill A
J Parasitol; 2005 Jun; 91(3):657-65. PubMed ID: 16108562
[TBL] [Abstract][Full Text] [Related]
39. Protective immunity induced by rPb27 of Paracoccidioides brasiliensis.
Reis BS; Fernandes VC; Martins EM; Serakides R; Goes AM
Vaccine; 2008 Oct; 26(43):5461-9. PubMed ID: 18722494
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
